Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Correction to: [89Zr]Zr‑huJ591 immuno‑PET targeting PSMA in IDH mutant anaplastic oligodendroglioma.
Correction to: [89Zr]Zr‑huJ591 immuno‑PET targeting PSMA in IDH mutant anaplastic oligodendroglioma.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 10, 2022
[89Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendroglioma.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 03, 2021
18F-Fluorocholine PET uptake correlates with pathologic evidence of recurrent tumor after stereotactic radiosurgery for brain metastases.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 12, 2019
Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 15, 2019
Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma.
Journal: Nature
Published: June 03, 2018
Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 24, 2018
Incidence of Prolonged Systemic Steroid Treatment after Surgery for Acoustic Neuroma and Its Implications.
Journal: Journal of neurological surgery. Part B, Skull base
Published: November 19, 2017
Tumor mutational load predicts survival after immunotherapy across multiple cancer types.
Journal: Nature genetics
Published: August 18, 2017
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.
Journal: Cancer discovery
Published: June 01, 2017
Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
Journal: International journal of radiation oncology, biology, physics
Published: January 30, 2017
Clinical outcomes of patients with limited brain metastases treated with hypofractionated (5×6Gy) conformal radiotherapy.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: January 09, 2017
Last Updated: 09/26/2026